Kainos Medicine

284620 · KOSDAQ

Public Market Listing

284620KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for Kainos Medicine are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 2
FAF1Small molecule
Parkinson's Disease
Phase 1
HIV reverse transcriptaseSmall molecule
HIV

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Quarterly & interim (2)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-H1$0.4M———report ↗
View 1 more
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-Q1$0.2M———report ↗

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$0.4M———report ↗

Kainos Medicine reported revenue of $0.44M, down 95.9% YoY for fiscal year 2024.

Figures only: this period's report disclosed no narrative text

View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2023-FY$11M———report ↗